<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05056649</url>
  </required_header>
  <id_info>
    <org_study_id>2020PI049</org_study_id>
    <nct_id>NCT05056649</nct_id>
  </id_info>
  <brief_title>The Role of the GP in the Management of Ambulatory Heart Failure</brief_title>
  <acronym>GPsHF</acronym>
  <official_title>The Role of the GP in the Management of Ambulatory Heart Failure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Jean-Marc BOIVIN</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Central Hospital, Nancy, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To describe the causes mentioned by general practitioners, explaining the under-treatment of&#xD;
      the three main treatments for heart failure with impaired ejection fraction (ARS blockers of&#xD;
      the type ACEinhibitor/ARA2/ARNi, ß- and/or anti-aldosterone).&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 1, 2021</start_date>
  <completion_date type="Anticipated">June 2023</completion_date>
  <primary_completion_date type="Anticipated">June 1, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Quantitative analysis of verbatims after grouping</measure>
    <time_frame>Through study completion, an average of 1 year</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>Heart Failure Patients with impaired ejection fraction</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Heart failure patients with impaired ejection fraction (LVEF &lt; 40%), under 85 years of age,&#xD;
        admitted to the emergency department for cardiac decompensation and hospitalised in the&#xD;
        aftermath of this decompensation, for whom the sum of the doses of ACE inhibitor or ARB2 +&#xD;
        BB + aldosterone antagonist is less than 50% of the dose required for this patient&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients with a previous diagnosis of heart failure with impaired ejection fraction&#xD;
             (LVEF &lt; 40%)&#xD;
&#xD;
          -  Under 85 years of age&#xD;
&#xD;
          -  Admitted to an Emergency department for cardiac decompensation&#xD;
&#xD;
          -  Hospitalized following this decompensation&#xD;
&#xD;
          -  Not deceased within one month of hospitalisation&#xD;
&#xD;
          -  Whose sum of the doses of ACEI or ARB2 + BB + aldosterone antagonist is less than 50%&#xD;
             of the dose required for this patient* (definition in annex)&#xD;
&#xD;
          -  Who did not object within one month of being informed&#xD;
&#xD;
        Exclusion Criteria:- Patient objecting to the use of their data&#xD;
&#xD;
          -  Patient who is a minor&#xD;
&#xD;
          -  Patient who does not have a general practitioner&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jean-Marc BOIVIN, MD,PhD</last_name>
    <phone>3 83 15 73 11</phone>
    <phone_ext>33</phone_ext>
    <email>jm.boivin@chru-nancy.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Nicolas GIRERD, MD, PhD</last_name>
    <phone>383 5 7322</phone>
    <phone_ext>33</phone_ext>
    <email>n.girerd@chru-nancy.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CHRU of Nancy</name>
      <address>
        <city>Vandœuvre-lès-Nancy</city>
        <zip>54500</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Jean-Marc BOIVIN, MD, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Jean-Marc BOIVIN, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>May 11, 2021</study_first_submitted>
  <study_first_submitted_qc>September 23, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 24, 2021</study_first_posted>
  <last_update_submitted>September 23, 2021</last_update_submitted>
  <last_update_submitted_qc>September 23, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 24, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Central Hospital, Nancy, France</investigator_affiliation>
    <investigator_full_name>Jean-Marc BOIVIN</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

